
Stryker Corporation
SYK
Updated: 23/09/2026, 20:27:26
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
No summaries found.
The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.
- Share price
- $272.36
- Market cap
- $104.41B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Kevin A. Lobo
- Employees
- 56,000
- IPO date
- 17/03/1980
- Beta
- 0.768
- Last dividend
- $0.00
- Day range
- $271.51 – $277.10
- 52-week range
- $267.00 – $392.55
- 1-day performance
- -0.99%
- 1-year performance
- 2.01%
- Current drawdown (1Y)
- -30.62%
- CIK
- 0000310764
- CUSIP
- 863667101
- ISIN
- US8636671013
- Created
- 07/12/2025, 14:28:16
- Last update
- 23/09/2026, 20:27:26
Track Stryker Corporation with an AI analyst
See which prediction-market events move SYK, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Zacks Investment Research • STOCK • 12/06/2026, 16:20:36
Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures
Zacks Investment Research • STOCK • 04/06/2026, 13:25:18
Stryker Launches Pangea Plating System in Europe for Fracture Fixation
Zacks Investment Research • STOCK • 27/05/2026, 14:41:16
Stryker Launches Pangea Plating System and Completes First Case in Europe
Business Wire • STOCK • 26/05/2026, 04:10:00
Stryker Corporation (SYK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 13/05/2026, 21:20:48
Stryker (NYSE: SYK) Navigates Q1 Earnings Miss Amid Cyber Incident and Strategic Growth
Market Data • Market Data • 02/05/2026, 04:12:59
Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption
Zacks Investment Research • STOCK • 01/05/2026, 13:31:27
Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript
Seeking Alpha • STOCK • 01/05/2026, 02:41:32
Stryker (SYK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research • STOCK • 30/04/2026, 21:01:06
Stryker (SYK) Q1 Earnings and Revenues Lag Estimates
Zacks Investment Research • STOCK • 30/04/2026, 20:30:15
Stryker to Report Q1 Earnings: What's in Store for the Stock?
Zacks Investment Research • STOCK • 28/04/2026, 11:50:31
Wall Street's Insights Into Key Metrics Ahead of Stryker (SYK) Q1 Earnings
Zacks Investment Research • STOCK • 27/04/2026, 12:15:14